Cornea neovascularisation treatment

Cornea neovascularisation treatment
An expert panel of ophthalmologists have published a consensus statement online in the British Journal of Ophthalmology on the management of neovascularisation associated with corneal diseases. The panel call for a framework to manage the disorder more efficiently, including the use of antiangiogenic drugs. 'There is a significant unmet need in the treatment of corneal neovascularisation. We believe that this could be met by using novel antiangiogenic therapies, which will eventually become an integral part of our treatment strategy,' explained Dr Claus Cursiefen, chairman and professor Department of Ophthalmology, University of Cologne, Germany, a panel participant and lead author for the consensus statement while at Friedrich-Alexander University Erlangen-Nürnberg. 'The panel believes that a framework for clinical evaluation and agreement on clinically relevant end points will assist future drug development and support regulatory authorities during their review of clinical trial data. This consensus statement provides an initial step in proposing this new framework.'
Latest Articles
Addressing Postoperative Visual Complications

Managing aberrations after laser refractive surgery requires a multi-layered approach.

Read more...

3D Printing Helps Transform Ukrainian Eye Care

The country’s ophthalmologists offer valuable experience in treating ocular trauma and prosthesis design.

Read more...

Winning Essay Says ‘Collective Desire’ Must Drive DEI Implementation

Read more...

Emerging Microbial Trends That Could Affect Your Practices

A triptych of challenges paints a concerning picture for ophthalmologists across the globe.

Read more...

Improving Outcomes with Laser-Assisted Surgery

Femtosecond laser offers a multifunctional tool for improving the safety and efficacy of cataract and refractive lens exchange procedures.

Read more...

Could the Corneal Transplant Pool Increase?

Modifying or discarding major contraindications for keratoplasty could mean more patients have their sight restored.

Read more...

Matching Premium IOLs to Visual Lifestyles

From monofocal to full-range solutions, each practice needs comprehensive understanding.

Read more...

Going Dutch on Acanthamoeba Keratitis

A world-first trial suggests a new medication could beat the disease.

Read more...

Avoiding Intracorneal Ring Segment Complications

Femtosecond lasers are helping improve refractive results with fewer problems.

Read more...

Fine-Tuning IOLs After Surgery

Lens power adjustment technology is developing quickly.

Read more...